CVE-2026-100560: high-severity vulnerability in OpenClaw
OpenClaw before 2026.8.1 Reusable Exec Approvals Authorization Bypass
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 7.7epss 0.6%
OpenClaw versions before 2026.8.1 contain an authorization bypass vulnerability where Allow Always approvals for exact commands persist as path-only grants on macOS and Linux. Attackers can reuse the same executable with different arguments to execute commands without triggering new approval prompts, potentially accessing files or internal services.
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
Affected products
OpenClaw · OpenClawRelated CVEs — OpenClaw
In the same product, most dangerous first.
CVE-2026-25253HIGHCVE-2026-25253EPSS 32.4%CVE-2026-44112HIGHOpenClaw < 2026.4.22 - Symlink Swap Race Condition in OpenShell FS Bridge WritesEPSS 7.3%CVE-2026-32917CRITICALOpenClaw < 2026.3.13 - Remote Command Injection via Unsanitized iMessage Attachment Paths in SCPEPSS 2.1%CVE-2026-3689MEDIUMOpenClaw Canvas Path Traversal Information Disclosure VulnerabilityEPSS 1.2%CVE-2026-32052MEDIUMOpenClaw < 2026.2.24 - Hidden Command Execution via Shell-Wrapper Positional argv CarriersEPSS 1.1%CVE-2026-53822HIGHOpenClaw < 2026.5.18 - Command Argument Modification via Shell Wrapper Between Approval and ExecutionEPSS 1.1%